X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
amg-531 (57) 57
index medicus (42) 42
humans (41) 41
hematology (30) 30
purpura, thrombocytopenic, idiopathic - drug therapy (28) 28
efficacy (27) 27
romiplostim (26) 26
platelet count (25) 25
receptors, fc - therapeutic use (25) 25
thrombopoietin (24) 24
eltrombopag (23) 23
male (22) 22
purpura (22) 22
female (20) 20
receptors, fc - administration & dosage (18) 18
adult (17) 17
recombinant fusion proteins - therapeutic use (17) 17
thrombopoietin - therapeutic use (17) 17
immune thrombocytopenic purpura (16) 16
receptors, thrombopoietin - agonists (16) 16
management (15) 15
splenectomy (15) 15
thrombocytopenia (15) 15
chronic itp (14) 14
middle aged (14) 14
pharmacology & pharmacy (13) 13
recombinant fusion proteins - administration & dosage (13) 13
recombinant fusion proteins - adverse effects (13) 13
safety (13) 13
aged (12) 12
benzoates - therapeutic use (12) 12
hydrazines - therapeutic use (12) 12
immune thrombocytopenia (12) 12
pyrazoles - therapeutic use (12) 12
thrombocytopenic purpura (12) 12
thrombopoietin - administration & dosage (12) 12
thrombopoietin - adverse effects (12) 12
treatment outcome (12) 12
adult patients (11) 11
adults (9) 9
care and treatment (9) 9
carrier proteins - therapeutic use (9) 9
chronic disease (9) 9
in-vitro (9) 9
itp (9) 9
oncology (9) 9
pharmacokinetics (9) 9
recombinant fusion proteins (9) 9
thrombocytopenia - drug therapy (9) 9
thrombopoiesis-stimulating peptibody (9) 9
double-blind (8) 8
medicine & public health (8) 8
dose-response relationship, drug (7) 7
idiopathic thrombocytopenic purpura (7) 7
pharmacodynamics (7) 7
platelet production (7) 7
analysis (6) 6
blood platelets - drug effects (6) 6
carrier proteins - administration & dosage (6) 6
clinical trials (6) 6
internal medicine (6) 6
thrombopoiesis (6) 6
time factors (6) 6
aged, 80 and over (5) 5
autoantibodies (5) 5
benzoates - adverse effects (5) 5
carrier proteins - adverse effects (5) 5
double-blind method (5) 5
drug therapy (5) 5
growth (5) 5
hydrazines - adverse effects (5) 5
medical colleges (5) 5
medicine, general & internal (5) 5
open-label (5) 5
platelets (5) 5
purpura, thrombocytopenic, idiopathic - blood (5) 5
pyrazoles - adverse effects (5) 5
rituximab (5) 5
therapy (5) 5
abridged index medicus (4) 4
adolescent (4) 4
benzoates - administration & dosage (4) 4
c-mpl (4) 4
child (4) 4
child, preschool (4) 4
children (4) 4
clinical trials as topic (4) 4
high-dose dexamethasone (4) 4
hydrazines - administration & dosage (4) 4
immunotherapy (4) 4
purpura, thrombocytopenic, idiopathic - complications (4) 4
pyrazoles - administration & dosage (4) 4
randomized controlled trials as topic (4) 4
thrombopoiesis - drug effects (4) 4
thrombopoietin receptor agonist (4) 4
administration, oral (3) 3
amg 531 (3) 3
animals (3) 3
biology (3) 3
carrier proteins - pharmacology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 02/2008, Volume 371, Issue 9610, pp. 395 - 403
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2013, Volume 161, Issue 3, pp. 411 - 423
Journal Article
Journal Article
Blood, ISSN 0006-4971, 03/2009, Volume 113, Issue 10, pp. 2122 - 2123
Journal Article
by Li, H and Yang, H and Liu, W.-J
European Review for Medical and Pharmacological Sciences, ISSN 1128-3602, 2018, Volume 22, Issue 18, pp. 6162 - 6169
OBJECTIVE: We aimed to analyze the efficacy and safety of romiplostim in the treatment of primary immune thrombocytopenia (ITP) in children. MATERIALS AND... 
Romiplostim | Immune thrombocytopenic | Children | Meta-analysis | DIAGNOSIS | MANAGEMENT | SAFETY | THROMBOPOIETIN | IMMUNE THROMBOCYTOPENIA | AMG-531 | IDIOPATHIC-THROMBOCYTOPENIC-PURPURA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2009, Volume 161, Issue 2, pp. 482 - 482
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 4/2019, Volume 25, Issue 3, pp. 719 - 723
Romiplostim is a thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia purpura. When following FDA-approved romiplostim... 
thrombopoietin receptor agonist | EFFICACY | ONCOLOGY | benign hematology | AMG-531 | GROWTH | RECEPTOR | PHARMACOLOGY & PHARMACY | romiplostim | Immune thrombocytopenic purpura | THROMBOPOIETIN | Mitigation | Thrombocytopenia | Dosing | Purpura | Case reports | Variations | Platelets | Patients | Thrombopoietin
Journal Article
Haematologica, ISSN 0390-6078, 06/2013, Volume 98, Issue 6, pp. 881 - 887
Journal Article
Journal Article